Found on pharmacist.com
Group by:
Title Date Type
New Ebola tactics raise hope but may sow confusion
New York Times (05/24/18) McNeil, Donald
Health experts warn that although there is optimism that the Ebola outbreak in central Africa can still be quickly contained, the fight is already becoming more complex. A new vaccine already in use has raised hopes that the outbreak will be quickly extinguished. Nonetheless, there may be confusion…
May 24, 2018 Publication Pharmacy Today Daily Edition
FDA approves a new treatment for PKU, a rare and serious genetic disease
FDA News Release (05/24/18)
FDA on Thursday approved pegvaliase-pqpz (Palynziq—BioMarin Pharmaceutical) for adults with a rare and serious genetic disease known as phenylketonuria (PKU). Patients with PKU are born with an inability to break down phenylalanine (Phe), an amino acid present in protein-containing foods and…
May 24, 2018 Publication Pharmacy Today Daily Edition
TB: Pharmacists develop new substance to counteract antimicrobial resistance
ScienceDaily (05/23/18)
Pharmacists at Martin Luther University Halle-Wittenberg (MLU) have discovered a way to increase the efficacy of a common tuberculosis (TB) agent while simultaneously reducing resistance to it, according to new research in Molecules. TB is typically treated with antibiotics. "Increasingly, however…
May 24, 2018 Publication Pharmacy Today Daily Edition
Mepivacaine is found to be an effective spinal anesthetic for knee replacement surgery
News-Medical.net (05/09/2018)
Mepivacaine, a numbing medication that vanished from operating rooms decades ago, may get new life as a spinal anesthetic for knee replacement surgery. A pair of trials—a retrospective review and a small, randomized study—suggest that the agent manages pain as effectively as bupivacaine…
May 24, 2018 Publication Pharmacy Today Daily Edition
Cancer drug spending doubled in last 5 years, report says
NBCNews.com (05/24/18) Fox, Maggie
Spending on cancer drugs has doubled over the past 5 years, according to a new report from The IQVIA Institute for Human Data Science, formerly IMS Health and Quintiles. The average cost of a new drug released in 2017 was $150,000. Those drug costs are expected to double again by 2022, the report…
May 24, 2018 Publication Pharmacy Today Daily Edition
Costs for older adults jump as generic drugs move to higher formulary tiers in Part D plans
AJMC.com (05/22/18) Inserro, Allison
Older adults with Medicare Part D plans are paying more for generic prescriptions even as the market price of these drugs remains unchanged, according to an Avalere analysis. This is because over time the generic drugs are being placed on higher formulary tiers where patients pay greater out-of-…
May 24, 2018 Publication Pharmacy Today Daily Edition
Improving pharmacy performance by prioritizing patient needs
Drug Store News (05/21/18) Salazar, David
Cardinal Health's Reimbursement Consulting Services (RCS) is broadening how it helps pharmacists focus on their patients. The key components of RCS are the RCS dashboard and professional consultants, who work with pharmacists to help identify new or overlooked opportunities for reimbursement or…
May 24, 2018 Publication Pharmacy Today Daily Edition
Pfizer used charity to mask heart drug price hikes, U.S. says
Bloomberg (05/24/18) Langreth, Robert
Pfizer will pay the U.S. government nearly $24 million as part of a settlement to resolve allegations that it funneled money through a foundation resulting in illegal kickbacks. The company is not admitting wrongdoing or liability as part of the settlement announced Thursday with the Department of…
May 24, 2018 Publication Pharmacy Today Daily Edition
Kansas task force considers injecting urgency into tracking of prescription medicines
Topeka Capital-Journal (KS) (05/25/18) Carpenter, Tim
The task force appointed by Gov. Jeff Colyer of Kansas to help the state address substance use disorders Thursday discussed mandating that medical professionals participate in the state’s prescription tracking system to help identify addicts obtaining medicine at multiple pharmacies and in…
May 24, 2018 Publication Pharmacy Today Daily Edition
Six states sue maker of oxycodone as they battle expenses, human costs of opioid crisis
USA Today (05/15/18) Moritz, John C.
Attorneys general in Texas, Florida, Nevada, North Carolina, North Dakota, and Tennessee have filed lawsuits in state courts against Purdue Pharma, the maker of oxycodone (OxyContin), for its role in the nation's opioid crisis. Texas' lawsuit accuses Purdue of aggressively selling its products "…
May 24, 2018 Publication Pharmacy Today Daily Edition